Inquiry list (0)
Solutions for Radiochemicals
We are pleased to offer a broad selection of PET and SPECT precursors, reference standards, reagent kits and consumables. Our products have been developed for the production of 18F ,11C , 68Ga , 177Lu tracers, with the mainstream synthesis modules
Products and Services
Years of Experience
RTU Kits Developed
Global Clients
Employees

Huayi Technology's Recap of the 2023 European Exhibitions
Jiangsu Huayi Technology Co., Ltd. (Huayi) Shines Bright at the 2023 WMIC and EANM Annual Conference.

Huayi and Chulalongkorn University and Mahidol University in Thailand started in-depth cooperation
Recently, Prof. Opa Vajragupta and Prof. Pornchai Rojsitthisak of Chulalongkorn University and Prof. Kittisak Sripha and Prof. Satsawat Visansirikul of Mahidol University visited our company, Jiangsu Huayi Technology Co., Ltd. (Huayi). Roujian Lu, Vice President of the company and General Manager of Huayi Isotopes Co., a division of Jiangsu Huayi Technology Co., Ltd. warmly welcomed the guests from Thailand with his co-workers.

Conference News| May and June Exhibition Review of Huayi lsotopes
As the COVID-19 continues to affect the world and the challenges of radiopharmaceutical development and innovation become more prominent, we are more eager to innovate breakthroughs and seek global partners to enhance our insights and business capabilities.

The annual meeting of the European Association of Nuclear Medicine
Founded in 1985, the European Union of Nuclear Medicine (EANM) is a European non-profit medical association for nuclear medicine that promotes science education in nuclear medicine.

The annual International Conferences on Radionuclide Therapy (14thICRT)
The 14th International Conference on Radiopharmaceutical Therapy was held in Nanjing. This conference On August 21-25, 2019. The conference have several subject, including the integration of diagnosis and treatment of cardiovascular and cerebrovascular diseases, prostate cancer, neuroendocrine tumors and other diseases, as well as quality control and clinical care in nuclear medicine.